Subtotal: R9 500,00
NOVA Versugen
R1 300,00
-
Blood vessel support
-
Cardiovascular wellness
-
Anti-aging
-
Recovery support
Guarantee safe & secure checkout
On all order
Description
-
Blood vessel support
-
Cardiovascular wellness
-
Anti-aging
-
Recovery support
Additional information
| Colour | Emerald Green, Royal Blue, Burnt Orange, Turquoise Teal, Mustard Yellow |
|---|
Quick Comparison
| NOVA Versugen remove | 8-in-1 Body Contouring & Slimming Treatment remove | HDL Semag 10 remove | Nova Cardiogen remove | HDL Retat 32 remove | BP Retat 64 remove | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | NOVA Versugen remove | 8-in-1 Body Contouring & Slimming Treatment remove | HDL Semag 10 remove | Nova Cardiogen remove | HDL Retat 32 remove | BP Retat 64 remove | ||||||||||||
| Image | |  | | | | | ||||||||||||
| SKU | IN_LK-28 | IN_LK-11 | IN_LK-16 | IN_LK-9 | IN_LK-4 | |||||||||||||
| Rating | ||||||||||||||||||
| Price | R1 300,00 | R56,00 | R1 450,00 | R1 300,00 | R2 100,00 | R4 300,00 | ||||||||||||
| Stock | ||||||||||||||||||
| Weight | N/A | N/A | N/A | N/A | N/A | N/A | ||||||||||||
| Dimensions | N/A | N/A | N/A | N/A | N/A | N/A | ||||||||||||
| Additional information |
|
|
|
|
|
| ||||||||||||
| Description |
| Advanced Non-Surgical Fat Reduction and Body Sculpting Our professional 8-in-1 slimming system combines multiple technologies to help reduce fat, tighten skin, smooth cellulite, | Semaglutide activates the GLP-1 (glucagon-like peptide-1) receptor, producing multiple downstream effects: enhanced insulin secretion in response to meals, suppressed glucagon output, delayed gastric emptying, and reduced appetite signals. | Cardiogen is a premium cardiovascular-support formula designed to improve heart health, enhance circulation, and support healthy blood pressure levels. | Retatrutide is a medicine for weight loss and weight maintenance that contains the active substance Retatrutide. |
| ||||||||||||
| Add to cart |
Reviews
There are no reviews yet.